Despite advances in acute stroke management and established secondary prevention strategies, recurrent ischemic stroke remains a substantial and persistent clinical challenge. A significant proportion of patients experience recurrent events within months to years of their index stroke or high-risk transient ischemic attack, even when treated according to guideline-directed antiplatelet therapy. Current approaches to secondary stroke prevention are constrained by a narrow therapeutic window featuring platelet- and coagulation-mediated pathways. FXI/FXIa inhibition represents a fundamentally different anticoagulation strategy, selectively targeting pathologic thrombosis within the intrinsic pathway while largely preserving physiologic hemostasis. In this activity, expert faculty will review strategies to identify patients at high risk for secondary stroke, how to personalize therapy based on patient-specific thromboembolic and bleeding risk factors, and the potential role of FXI/FXIa inhibitor therapies in this setting.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 1301 Virginia Drive
Pricing
CME included with membership
| Free Registration | Free |
| Tufts-Affiliated HCP - Early Bird (by 10/5/26) | $75 |
| Tufts-Affiliated HCP - Standard | $175 |
| Trainees & Allied Health - Early Bird (by 10/5/26) | $75 |
| Trainees & Allied Health - Standard | $175 |
| Physicians - Early Bird (by 10/5/26) | $150 |
+3 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Neurology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1 credit
- Paid · fee on provider site
- Commercial Support
-
ReleasedSep 10, 2026
-
Last day to claim creditSep 11, 2027 11 months left
-
Global Learning Collaborative Beyond Steroids in Warm AIHA: A Practical Framework for Diagnosis, Relapse Management, and Emerging Therapies
-
Global Learning Collaborative What the Evidence Demands: A Clinician s Decision Framework for LR-MDS Anemia Management
-
Global Learning Collaborative From Evidence to Action: Advancing Care in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome
